Evidence map›Paper›PMID 23903549›Full record

ArticleJournal of clinical microbiology2013

Comparison of the FDA-approved CDC DENV-1-4 real-time reverse transcription-PCR with a laboratory-developed assay for dengue virus detection and serotyping.

Jesse J Waggoner, Janaki Abeynayake, Malaya K Sahoo, Lionel Gresh, Yolanda Tellez, Karla Gonzalez, Gabriela Ballesteros, Frances P Guo, Angel Balmaseda, Kumudu Karunaratne and 2 more

Open access · bronzeAbstract readComparative StudyEvaluation Study
In one paragraph

Article in Journal of clinical microbiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 1 pooled it
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 1 synthesis or guideline pooled it, 71 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 3 countries.

Jesse J WaggonerDivision of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, California, USA.
Janaki Abeynayake
Malaya K Sahoo
Lionel Gresh
Yolanda Tellez
Karla Gonzalez
Gabriela Ballesteros
Frances P Guo
Angel Balmaseda
Kumudu Karunaratne
Eva Harris
Benjamin A Pinsky
Stanford University · USMinisterio de Salud · NILady Ridgeway Hospital for Children · LKUniversity of California, Berkeley · US

Funding

Vaccines and Diagnostics TrialsU54AI065359 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI BARBOUR, ALAN G. · 2005 to 2013
$88.8M
Stanford Global Health Consortium: Innovation, Design, Evaluation, and ActionRC4TW008781 · FIC · STANFORD UNIVERSITY · PI BARRY, MICHELE · 2010 to 2010
$8.1M
EMERGING INFECTIOUS DISEASEST32AI007502 · NIAID · STANFORD UNIVERSITY · PI Prasanna Jagannathan, DAVID A. RELMAN · 1995 to 2026
$6.8M
Epidemiological, Clinical & Immunological Studies of Zika, dengue and chikungunyaR01AI099631 · NIAID · SUSTAINABLE SCIENCES INSTITUTE · PI BALMASEDA, ANGEL LAZARO · 2012 to 2021
$1.8M
CCR NIH HHS RC4 TW008781-01FIC NIH HHS RC4 TW008781NIAID NIH HHS HHSN272201000026CNIAID NIH HHS R01 AI099631NIAID NIH HHS R01AI099631NIAID NIH HHS T32 AI007502NIAID NIH HHS U54 AI065359NIAID NIH HHS U54AI65359
6 · The paper itself

Abstract

Dengue virus (DENV) is the agent of the most common vector-borne disease worldwide. Using 199 clinical samples collected from Nicaragua and Sri Lanka, a laboratory-developed DENV multiplex real-time reverse transcription-PCR (rRT-PCR) proved more clinically sensitive than the FDA-approved CDC assay for DENV serotypes 1 to 4 when measured against a composite reference standard, with sensitivities of 97.4% versus 87.1%, respectively.

Indexed as

DengueDengue VirusHumansMolecular Diagnostic TechniquesNicaraguaReal-Time Polymerase Chain ReactionSensitivity and SpecificitySerotypingSri LankaVirology

Identifiers

PMID23903549
PMCPMC3811623
OpenAlexW2115822399

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.